Element ListExplanation
Introduction Bupa Arabia for Cooperative Insurance Co. announces:

The appointment of Mrs. Joy Linton, as Non-Executive Board Member, representing the foreign shareholder, Bupa Investments Overseas Limited (BIOL), effective 1 December 2019G, as approved by the Board on 19 November 2019G, due to the major shareholder replacing their previously resigned Board member representative.

Element ListExplanation
Appointed Member Name Mrs. Joy Linton
Membership Type Non- Executive
Membership Start Date 2019-12-01 Corresponding to 1441-04-04
Brief Resume of the Appointed Member That Mrs. Joy Linton is based in the UK and is an executive director, appointed during 2016, of the main Board of Bupa, the international health insurance and provision group based in London, United Kingdom, which owns the Bupa Arabia major shareholder BIOL. Mrs. Linton has been with Bupa since 2011 and is also a Board member of BIOL, is the Chief Financial Officer of Bupa, and a member of its Executive Team. She is also a Non-Executive Director of Max Bupa, Bupa’s associate health insurance business in India.

Mrs. Linton has over 30 years’ experience in financial and strategic roles in Australia and the UK and prior to joining Bupa was the CFO of National Foods, one of Australia’s largest food and beverage companies.

Mrs. Linton has a Bachelor's degree in Commerce, from the University of Melbourne, Australia, in 1987, is a Fellow of the Financial Services Institute of Australasia, since 2004, and is a member of the Australian Institute of Company Directors, since 2010.

Element ListExplanation
Date of Board Meeting in which Appointed New Member(s) were Appointed 2019-11-19 Corresponding to 1441-03-22
Board Approval This Board member appointment is still subject to the approval of the shareholders in the next General Assembly meeting, which will be advised at a later date.

The Capital Market Authority and the Saudi Stock Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.

Company Profile


Company Profile


Last Price Net Change
129.8 4.4 (+3.51%)
Value Traded (SAR) Volume Traded
73,071,683.4 564,915